Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers

British Journal of Anaesthesia

Volumn 100, Issue 5, 2008, Pages 631-636

  McCormick, A S M ^a,c   Thomas, V L ^a   Berry, D ^b   Thomas, P W ^c,d  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b Medical Toxicology Unit   (United Kingdom)

^c POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d BOURNEMOUTH UNIVERSITY   (United Kingdom)

Author keywords

Pharmacokinetics, midazolam; Premedication, midazolam; Sedation

Indexed keywords

MIDAZOLAM; HYPNOTIC SEDATIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DYSPNEA; FEMALE; HICCUP; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; NOSE IRRITATION; NOSE SECRETION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; SECRETION; SEDATION; SIDE EFFECT; VISUAL ANALOG SCALE; WHEEZING; BLOOD; CONSCIOUS SEDATION; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; NEBULIZER; PREMEDICATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ADULT; CONSCIOUS SEDATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FLICKER FUSION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; NEBULIZERS AND VAPORIZERS; PREMEDICATION;

EID: 43249083716     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen072     Document Type: Article

References (27)

1. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther 1981; 30: 653-61
2. Wilton NCT, Leigh J, Rosen DR, Pandit UA. Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology 1988; 69: 972-5
3. Theroux MC, West DW, Corddry DH, et al. Efficacy of intranasal midazolam in facilitating suturing of lacerations in preschool children in the emergency department. Pediatrics 1993; 91: 624-7
4. Slover R, Dedo W, Schlesinger T, Mattison R. Use of intranasal midazolam in preschool children (abstr). Anesth Analg 1990; 70: S377
5. Cheng ACK. Intranasal midazolam for rapidly sedating an adult patient. Anesth Analg 1993; 76: 904
6. Fisgin T, Gurer Y, Tezic T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol 2002; 17: 123-6
7. Lugo RA, Fishbein M, Nahata MC, Lininger B. Complication of intranasal midazolam. Pediatrics 1993; 92: 638
8. Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656-9
9. Turner P. Critical flicker frequency and centrally-acting drugs. Br J Ophthalmol 1968; 52: 245-9
10. Turner P, Sneddon JM, Smart JV. Fall in critical flicker frequency associated with adaptation to intermittent light. Nature 1967; 214: 947
11. Lehmann B, Boulieu R. Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatography. J Chromatogr B: Biomed Sci Appl 1995; 674: 138-42
12. Rey E, Delaunay L, Pons G, et al. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 1991; 41: 355-7
13. Knoester PD, Jonker DM, van der Hoeven RTM, et al. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol 2002; 53: 501-7
14. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61: 27-35
15. Payne K, Mattheyse FJ, Liebenberg D, Dawes T. The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol 1989; 37: 267-72
16. Schwagmeier R, Alincic S, Striebel HW. Midazolam pharmacokinetics following intravenous and buccal administration. Br J Pharmacol 1998; 46: 203-6
17. Thummel KE, O'Shea D, Paine MF, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3Amediated metabolism. Clin Pharmacol Ther 1996; 59: 491-502
18. Björkman S, Rigemar G, Idvall J. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth 1997; 79: 575-80
19. Davis PJ, Tome JA, McGowan FX, Cohen IT, Latta K, Felder H. Preanesthetic medication with intranasal midazolam for brief pediatric surgical procedures. Anesthesiology 1995; 82: 2-5
20. Karl HW, Keifer AT, Rosenberger JL, Larach MG, Ruffle JM. Comparison of the safety and efficacy of intranasal midazolam or sufentanil for preinduction of anesthesia in pediatric patients. Anesthesiology 1992; 76: 209-15
21. Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal administration of midazolam for premedication of pediatric patients. Anesthesiology 1993; 78: 885-91
22. Dennis JH, Hendrick DJ. Design characteristics for drug nebulizers. J Med Eng Technol 1992; 16: 63-8
23. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child 1992; 67: 586-91
24. Newman SP, Pitcairn GR, Hooper G, Knoch M. Efficient drug delivery to the lungs from a continuously operated open-vent nebulizer and low pressure compressor system. Eur Respir J 1994; 7: 1177-81
25. Jaimovich DG, Osborne JS, Shabino CL. Comparison of intravenous and endotracheal administration of midazolam and the effect on pulmonary function and histology in the lamb model. Ann Emerg Med 1992; 21: 480-5
26. Persson MP, Nilsson A, Hartvig P. Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 1988; 43: 324-31
27. McCormick AS, Thomas VL. Bronchospasm during inhalation of nebulized midazolam. Br J Anaesth 1998; 80: 564-5